CN112807407A - Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis - Google Patents

Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis Download PDF

Info

Publication number
CN112807407A
CN112807407A CN202110249979.6A CN202110249979A CN112807407A CN 112807407 A CN112807407 A CN 112807407A CN 202110249979 A CN202110249979 A CN 202110249979A CN 112807407 A CN112807407 A CN 112807407A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
blood stasis
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110249979.6A
Other languages
Chinese (zh)
Inventor
李德伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110249979.6A priority Critical patent/CN112807407A/en
Publication of CN112807407A publication Critical patent/CN112807407A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis, which is characterized by comprising the following raw materials in parts by weight: 80-100 parts of radix curcumae, 40-50 parts of cassia twig, 200 parts of 150-materials of heracleum hemsleyanum michaux, 24-32 parts of elecampane, 40-50 parts of achyranthes root, 200 parts of 150-materials of gentiana macrophylla, 40-50 parts of safflower, 80-100 parts of white paeony root, 24-32 parts of prepared nux vomica, 24-32 parts of dragon's blood, 24-32 parts of frankincense, 40-50 parts of myrrh, 24-32 parts of vinegar-prepared corydalis tuber and 40-50 parts of pseudo-ginseng. Compared with the prior art, the traditional Chinese medicine preparation for promoting blood circulation and removing blood stasis, which is prepared by the invention, has the advantages of difficult moisture absorption, easy storage, stable quality, easy filling and the like, thereby making up the defects of the traditional bone and muscle pill preparation.

Description

Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation for promoting blood circulation and removing blood stasis.
Background
The bone and muscle pill is a traditional Chinese medicine preparation and has the effects of promoting blood circulation to remove blood stasis, relaxing muscles and tendons, dredging collaterals, dispelling wind and relieving pain. Can be used for treating hypertrophic spondylitis, cervical spondylosis, calcaneal spur, proliferative arthritis, Kaschin-Beck disease, etc., and has good clinical curative effect. The bone and muscle pills in the market at present are pills (big honeyed pills), tablets and capsules. The pill or tablet has large specific surface area, is easy to absorb moisture and generate caking and mildewing, brings great difficulty to production and storage, and is difficult to obtain a stable product.
Disclosure of Invention
In view of the above, the present invention aims to provide a blood circulation promoting and blood stasis removing traditional Chinese medicine preparation with the effects of convenient use, quick effect, good curative effect, etc.
In order to achieve the purpose, the invention provides the following technical scheme:
the traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis is characterized by comprising the following raw materials in parts by weight: 80-100 parts of radix curcumae, 40-50 parts of cassia twig, 200 parts of 150-materials of heracleum hemsleyanum michaux, 24-32 parts of elecampane, 40-50 parts of achyranthes root, 200 parts of 150-materials of gentiana macrophylla, 40-50 parts of safflower, 80-100 parts of white paeony root, 24-32 parts of prepared nux vomica, 24-32 parts of dragon's blood, 24-32 parts of frankincense, 40-50 parts of myrrh, 24-32 parts of vinegar-prepared corydalis tuber and 40-50 parts of pseudo-ginseng.
Preferably, the traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis comprises the following raw materials in parts by weight: 90 parts of radix curcumae, 45 parts of cassia twig, 180 parts of radix angelicae pubescentis, 28 parts of costustoot, 45 parts of radix achyranthis bidentatae, 180 parts of gentiana macrophylla, 45 parts of safflower, 90 parts of radix paeoniae alba, 30 parts of prepared nux vomica, 28 parts of dragon's blood, 30 parts of frankincense, 45 parts of myrrh, 27 parts of rhizoma corydalis processed with vinegar and 45 parts of pseudo-ginseng.
The main effects of the components of the invention are as follows:
the curcuma aromatica is a dried root tuber of curcuma wenyuwenyujin Y.H.Chenet C.Ling, curcuma longa Curcumalongal L., curcuma zedoaria Curcumakwangsiensis S.G.LeeetC.F.Liang or curcuma zedoaria Curcaeocauli Val.A traditional Chinese medicine for clinically treating thoracico-abdominal stabbing pain, thoracic obstruction, cardiodynia, amenorrhea, breast distending pain and other symptoms in traditional Chinese medicine has the effects of activating blood circulation to dissipate blood stasis, promoting qi circulation and resolving stagnation and the like.
Ramulus Cinnamomi has effects of promoting sweat secretion, relieving inflammation and pain, regulating gastrointestinal function and immunity, resisting virus, resisting allergy and lowering blood sugar.
Radix angelicae pubescentis: slightly warm in nature, pungent and bitter in flavor. It enters kidney and bladder meridians. [ EFFECT AND ACTION ] can dispel pathogenic wind, remove dampness, relieve arthralgia and alleviate pain. Belongs to wind-damp-dispelling and cold-dispersing herbs classified under wind-damp-dispelling herbs.
Costustoot: warm in nature, pungent and bitter in flavor. It enters spleen meridian, stomach meridian, large intestine meridian, triple energizer meridian and gallbladder meridian. [ EFFECT AND ACTION ] can promote the circulation of qi, alleviate pain, invigorate the spleen and promote digestion. Belongs to qi-regulating herbs.
The effects of achyranthes root are promoting blood circulation and removing blood stasis, tonifying liver and kidney, strengthening bones and muscles, inducing diuresis and treating stranguria and drawing blood downward. The clinical application is that the achyranthes root can activate blood, remove stasis and relieve pain, and treat various blood stasis blocking diseases. Second, niu xi is bitter in taste and can purge and descend, induce fire heat to descend, descend fire of inflammation, and treat hematemesis, epistaxis, gingival swelling and pain, aphtha and tongue. And the achyranthes root directly reaches the liver and kidney meridians, guides qi and blood downward and can treat liver-yang hyperactivity. And the achyranthes root has the effects of tonifying liver and kidney, strengthening muscles and bones, promoting blood circulation, dredging channels and benefiting joints, and can treat soreness and weakness of waist and knees and weakness of lower limbs by leading all the medicines to descend. Wu and niu xi can smooth joint, activate blood and alleviate pain, so it can cure arthralgia syndrome pain. Sixthly, achyranthes root can induce diuresis and remove blood stasis to treat stranguria, so it can treat bloody stranguria and dysuria.
The gentiana macrophylla has the effects of dispelling wind-damp and heat, dredging collaterals and relieving pain, and reducing deficiency heat and clearing damp-heat. The gentiana macrophylla has the functions of treating rheumatic arthralgia, spasm and urgency of muscles and tendons and bone joints and soreness, and can be applied in combination regardless of new or old cold and heat.
Safflower has the functions of promoting blood circulation, dredging meridian, removing blood stasis and relieving pain. Can be used for treating amenorrhea, dysmenorrhea, postpartum abdominal pain due to blood stasis, swelling and pain due to traumatic injury and blood stasis, and joint pain.
White peony root is a very good Chinese medicine and has unique curative effect in many formulas. Radix Paeoniae alba is cool, bitter and slightly cold in nature, has effects of suppressing hyperactive liver, relieving pain, astringing yin, arresting sweating, nourishing blood, replenishing blood, nourishing yin, suppressing hyperactive liver, relieving pain, and caring skin.
Prepared nux vomica is bitter in taste, cold in nature and toxic. Bitter herbs can descend and purge, vine can move and disperse in nature, and cold herbs can clear heat. Entering liver and spleen meridians, it has the actions of dissipating heat and resolving stasis, and is indicated for abscess, deep-rooted carbuncle and swelling pain. It is usually caused by the external infection of six excesses and the excessive intake of ointment and sorghum with the thick flavor of damp-heat and fire-toxin in the interior, or the external injury and the feeling of toxic qi, which causes the accumulation of pathogenic toxin, resulting in disharmony between ying and wei, blockage of meridians and stagnation of qi and blood. For treatment, vomiting nut, semen Strychni can dispel heat and resolve stasis, remove blood stasis and swelling, and relieve pain.
The main treatment effects of dragon's blood are as follows: first, activate blood and alleviate pain. Can be used for treating traumatic injury, internal injury, blood stasis and pain, dysmenorrhea, puerperal abdominal pain due to blood stasis, and pain of heart and abdomen due to blood stasis. Secondly, hemostasis is performed. The dragon's blood can not only dissipate blood stasis but also stop bleeding, has the characteristic of stopping bleeding without leaving blood stasis, and is suitable for bleeding caused by stagnation of blood stasis and non-meridian-tropism of blood.
The frankincense is a traditional Chinese medicine name, is resin seeped from the bark of the boswellia serrata or the congeneric plant of the family olive, and has the effects of relieving pain, diminishing swelling and promoting tissue regeneration. The medicine can enter heart and liver channels of human bodies, has slightly bitter taste, can play roles of dredging and discharging blood, promoting blood circulation to diminish inflammation, dissipating blood stasis to relieve pain, removing necrotic tissue and promoting tissue regeneration, and also belongs to a medicine commonly used in traumatology.
The medicine has no bitter, pungent and mild properties, enters heart, liver and spleen channels, belongs to one of the medicines for promoting blood circulation and removing blood stasis, and has the main effects of promoting blood circulation and relieving pain, and reducing swelling and promoting granulation.
The vinegar rhizoma corydalis is a traditional Chinese medicine, is a vinegar product of rhizoma corydalis, is pungent, bitter and warm in nature, and enters pericardium, liver, spleen and lung channels. Has effects in removing blood stasis, regulating qi-flowing, and relieving pain. Is mainly suitable for pains caused by stagnation of qi and blood, such as postpartum abdominal pain, menstrual pain, stomachache, chest stuffiness and pains, and symptoms such as abdominal distending pain, cold hernia, traumatic injury, rheumatic arthralgia and the like caused by stagnation of liver qi.
Notoginseng, the name of traditional Chinese medicine. Is dried root of Panax notoginseng (Burk.) F.H.Chen of Araliaceae. Has effects of removing blood stasis, stopping bleeding, promoting blood circulation, and relieving pain. It can be used for treating hemorrhage, traumatic injury, and swelling and pain due to blood stasis.
According to the technical scheme, compared with the prior art, the traditional Chinese medicine preparation for promoting blood circulation and removing blood stasis, which is prepared by the invention, has the advantages of difficulty in moisture absorption, easiness in storage, stable quality, easiness in filling and the like, so that the defects of the traditional bone and muscle pill preparation are overcome.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention discloses a traditional Chinese medicine preparation for promoting blood circulation and removing blood stasis, which has the effects of convenient use, quick response, good curative effect and the like.
The invention discloses a traditional Chinese medicine preparation for promoting blood circulation and removing blood stasis, which specifically comprises the following raw materials in parts by weight: 80-100 parts of radix curcumae, 40-50 parts of cassia twig, 200 parts of 150-materials of heracleum hemsleyanum michaux, 24-32 parts of elecampane, 40-50 parts of achyranthes root, 200 parts of 150-materials of gentiana macrophylla, 40-50 parts of safflower, 80-100 parts of white paeony root, 24-32 parts of prepared nux vomica, 24-32 parts of dragon's blood, 24-32 parts of frankincense, 40-50 parts of myrrh, 24-32 parts of vinegar-prepared corydalis tuber and 40-50 parts of pseudo-ginseng.
In order to further optimize the technical scheme, the method comprises the following raw materials in parts by weight: 90 parts of radix curcumae, 45 parts of cassia twig, 180 parts of radix angelicae pubescentis, 28 parts of costustoot, 45 parts of radix achyranthis bidentatae, 180 parts of gentiana macrophylla, 45 parts of safflower, 90 parts of radix paeoniae alba, 30 parts of prepared nux vomica, 28 parts of dragon's blood, 30 parts of frankincense, 45 parts of myrrh, 27 parts of rhizoma corydalis processed with vinegar and 45 parts of pseudo-ginseng.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other. The device disclosed by the embodiment corresponds to the method disclosed by the embodiment, so that the description is simple, and the relevant points can be referred to the method part for description.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims (2)

1. The traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis is characterized by comprising the following raw materials in parts by weight: 80-100 parts of radix curcumae, 40-50 parts of cassia twig, 200 parts of 150-materials of heracleum hemsleyanum michaux, 24-32 parts of elecampane, 40-50 parts of achyranthes root, 200 parts of 150-materials of gentiana macrophylla, 40-50 parts of safflower, 80-100 parts of white paeony root, 24-32 parts of prepared nux vomica, 24-32 parts of dragon's blood, 24-32 parts of frankincense, 40-50 parts of myrrh, 24-32 parts of vinegar-prepared corydalis tuber and 40-50 parts of pseudo-ginseng.
2. The traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight: 90 parts of radix curcumae, 45 parts of cassia twig, 180 parts of radix angelicae pubescentis, 28 parts of costustoot, 45 parts of radix achyranthis bidentatae, 180 parts of gentiana macrophylla, 45 parts of safflower, 90 parts of radix paeoniae alba, 30 parts of prepared nux vomica, 28 parts of dragon's blood, 30 parts of frankincense, 45 parts of myrrh, 27 parts of rhizoma corydalis processed with vinegar and 45 parts of pseudo-ginseng.
CN202110249979.6A 2021-03-08 2021-03-08 Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis Pending CN112807407A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110249979.6A CN112807407A (en) 2021-03-08 2021-03-08 Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110249979.6A CN112807407A (en) 2021-03-08 2021-03-08 Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis

Publications (1)

Publication Number Publication Date
CN112807407A true CN112807407A (en) 2021-05-18

Family

ID=75862971

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110249979.6A Pending CN112807407A (en) 2021-03-08 2021-03-08 Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis

Country Status (1)

Country Link
CN (1) CN112807407A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142928A (en) * 2011-12-07 2013-06-12 西安泰科迈医药科技有限公司 Iliacus muscle oral liquid and preparation method thereof
CN105770711A (en) * 2014-12-16 2016-07-20 康普药业股份有限公司 Gujinwan pharmaceutical composition (pharmaceutical composition for strengthening bones and muscles) and preparation method of pharmaceutical composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142928A (en) * 2011-12-07 2013-06-12 西安泰科迈医药科技有限公司 Iliacus muscle oral liquid and preparation method thereof
CN105770711A (en) * 2014-12-16 2016-07-20 康普药业股份有限公司 Gujinwan pharmaceutical composition (pharmaceutical composition for strengthening bones and muscles) and preparation method of pharmaceutical composition

Similar Documents

Publication Publication Date Title
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN100396328C (en) Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny
CN102038911A (en) Traditional Chinese medicine preparation for treating acute mastitis
CN104138486A (en) Traditional Chinese medicine for treating chronic epididymitis
CN106389947A (en) Traditional Chinese medicine for curing neonatal jaundice and preparation method thereof
CN112807407A (en) Traditional Chinese medicine preparation for promoting blood circulation to remove blood stasis
CN104997890B (en) A kind of Chinese materia medica preparation for treating fracture
CN106620471A (en) Traditional Chinese medicine composition for postoperative rehabilitation of bone fracture
CN106344754A (en) Unguent for treating haemorrhoids
CN102949507B (en) Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN104474153A (en) Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration
CN103330792B (en) Traditional Chinese medicine lotion for treating tinea pedes
CN104189777A (en) Traditional Chinese medicine preparation for treating mastitis
CN102847059A (en) Tablets for eliminating stasis, relieving pains and tonifying liver and kidney
CN101983681A (en) Medicament for treating abnormal leucorrhea
CN101693095A (en) Traditional Chinese medicine preparation for treating cirrhosis and liver ascites
CN107952057B (en) Traditional Chinese medicine preparation for treating acne
CN104138543A (en) Traditional Chinese medicine for treating epididymitis
CN1258375C (en) Method for preparing medicine for treating rheumatoid arthritis
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN105687917A (en) Oral solution for treating arthritis
CN104940869A (en) Traditional Chinese medicine composition for treating pain in the neck shoulder low-back and long-term denervation, and preparation method thereof
CN104688916A (en) TCM (Traditional Chinese Medicine) composition for treating psoriasis
CN101406518A (en) Pills for treating sciatica and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210518